Voyager Therapeutics Inc (NASDAQ:VYGR)
| 8.08 Delayed Data As of Feb 03 |  -0.80 / -9.01%Today’s Change | 2.86 Today|||52-Week Range 10.82 | +32.46% Year-to-Date |
Latest VYGR News | Press Releases
| Reata Pharmaceuticals, Inc. (RETA) Soars 6.3%: Is Further Upside Left in the Stock? Feb 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.88 |
| Today’s open | 9.24 |
| Day’s range | 7.84 - 9.24 |
| Volume | 14,366 |
| Average volume (3 months) | 251,249 |
| Market cap | $323.1M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -291.02% |
| Earnings growth (this year) | +38.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -78.14% |
| P/E ratio | NM |
| Price/Sales | 2.73 |
| Price/Book | 3.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RIGLRigel Pharmaceutical... | +0.03 | +1.69% |
| OTLKOutlook Therapeutics... | 0.00 | 0.00% |
| ---- | ||
| AUTLAutolus Therapeutics... | 0.00 | 0.00% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $37.4M |
| Annual profit (last year) | -$71.2M |
| Net profit margin | -190.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
